Journal article

Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies

S Plamondon, SC Ng, MA Kamm

Alimentary Pharmacology and Therapeutics | BLACKWELL PUBLISHING | Published : 2007

DOI: 10.1111/j.1365-2036.2006.03239.x

Citation metrics

56Web of Science
58Scopus

Keywords

Infliximab
Female
Middle Aged
Thalidomide
Life Sciences & Biomedicine
Tumor-Necrosis-Factor
Anti-Inflammatory Agents, Non-Steroidal
Alpha
Pharmacology & Pharmacy
Experience
Treatment Outcome
Male
Gastroenterology & Hepatology
Science & Technology
Open-Label
Retrospective Studies
Humans
Low-Dose Thalidomide
Adult
Maintenance Therapy
Trial
Crohn Disease